Ali H H, Lien C A, Witkowski T, Brull S J, Stout R G, Bartkowski R, Silverman D G, Patel S, Ascher J A, Goudsouzian N G
Department of Anaesthesia, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA.
J Clin Anesth. 1996 Jun;8(4):276-81. doi: 10.1016/0952-8180(96)85617-0.
To compare the safety and effectiveness of 0.25 mg divided doses of mivacurium chloride to succinylcholine for a 90-second tracheal intubation.
Randomized, double-blind, multicenter study in two groups.
Operating rooms at four university medical centers.
200 healthy ASA status I and II adult patients scheduled for elective surgery with general anesthesia and endotracheal intubation.
Patients were premedicated with 1 to 2 mg midazolam and 2 micrograms/kg fentanyl. Anesthesia was induced with 2 mg/kg propofol. Group A received 0.25 mg/kg mivacurium given as a divided dose (0.15 mg/kg followed in 30 seconds with 0.1 mg/kg). Group B (control) received 1.5 mg/kg succinylcholine (SCh) preceded two minutes earlier by 50 micrograms/kg d-tubocurarine (dtc).
Tracheal intubation grading, train-of-four response of the adductor pollicis, heart rate (HR), and mean arterial blood pressure (MAP) were measured and evaluated. Chi-square analysis was performed for comparison between Group A and Group B with respect to the frequency distribution of intubation using the scores excellent, good, and poor and not possible (combined). Group B had a significantly higher excellent score of intubation than Group A, 84% versus 56% (p < 0.0001). No significant difference was found between the two groups when the scores excellent and good were combined (Fisher's Exact test, p = 0.28). The changes in MAP and HR were similar for the two groups.
When Sch is not desirable, mivacurium 0.25 mg/kg given as a divided dose provides good to excellent intubation conditions 90 seconds after the initial dose without significant changes in MAP or HR. It can be an appropriate alternative for short surgical procedures. It must be emphasized that this conclusion does not apply to rapid-sequence induction-intubation.
比较0.25mg分次给药的米库氯铵与琥珀胆碱用于90秒气管插管的安全性和有效性。
两组随机、双盲、多中心研究。
四家大学医学中心的手术室。
200例拟行择期手术并接受全身麻醉和气管插管的健康ASA I级和II级成年患者。
患者术前使用1至2mg咪达唑仑和2μg/kg芬太尼进行预处理。用2mg/kg丙泊酚诱导麻醉。A组接受0.25mg/kg米库氯铵分次给药(0.15mg/kg,30秒后再给予0.1mg/kg)。B组(对照组)接受1.5mg/kg琥珀胆碱(SCh),两分钟前先给予50μg/kg右旋筒箭毒碱(dtc)。
测量并评估气管插管分级、拇内收肌的四个成串刺激反应、心率(HR)和平均动脉压(MAP)。采用卡方分析比较A组和B组在插管评分(优、良、差及无法评估(合并))频率分布方面的差异。B组插管优级评分显著高于A组,分别为84%和56%(p<0.0001)。将优级和良级评分合并后,两组间无显著差异(Fisher精确检验,p=0.28)。两组MAP和HR的变化相似。
当不适合使用琥珀胆碱时,0.25mg/kg分次给药的米库氯铵在首次给药90秒后可提供良好至优秀的插管条件,且MAP或HR无显著变化。它可作为短时间手术的合适替代药物。必须强调的是,该结论不适用于快速顺序诱导插管。